Dopamine D3 receptor ligands—Recent advances in the control of subtype selectivity and intrinsic activity
- 30 April 2007
- journal article
- review article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1768 (4), 871-887
- https://doi.org/10.1016/j.bbamem.2006.12.001
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Dopamine D2 and D3 receptors in human putamen, caudate nucleus, and globus pallidusSynapse, 2006
- Dopamine D3 receptor antagonists as therapeutic agentsDrug Discovery Today, 2005
- Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor functionNature Medicine, 2003
- Loss of response to levodopa in Parkinson’s disease and co-occurrence with dementia: role of D3 and not D2 receptorsBrain Research, 2002
- Neurochemical findings in the MPTP model of Parkinson's diseaseJournal of Neural Transmission, 2001
- D3 dopamine receptor, behavioral sensitization, and psychosisNeuroscience & Biobehavioral Reviews, 2001
- Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonistNature, 1999
- Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Dopamine D3 receptor mRNA and binding sites in human brainMolecular Brain Research, 1993
- Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neurolepticsNature, 1990